Patents by Inventor Nikhil Javant Kavimandan

Nikhil Javant Kavimandan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODIFIED RELEASE OF 4-METHYL-3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]-N-[5-(4-METHYL-1H-IMIDAZOL-1-YL)-3-(TRIFLOUOROMETHYL)PHENYL] BENZAMIDE SOLUBILIZED USING ORGANIC ACIDS
    Publication number: 20150273070
    Abstract: Soluble pharmaceutical compositions of nilotinib or a pharmaceutically acceptable salt thereof were invented using one or more organic acids that function as a solubilizing agent, increasing the bioavailability of nilotinib and supressing the food effect associated with certain compositions of nilotinib. The pharmaceutical compositions are in the form of solid oral dosage forms, including capsules and tablets.
    Type: Application
    Filed: June 13, 2012
    Publication date: October 1, 2015
    Applicant: Novartis AG
    Inventors: Shoufeng Li, Saran Kumar, Nikhil Javant Kavimandan, Enxian Lu
  • EXTENDED RELEASE GASTRO-RETENTIVE ORAL DRUG DELIVERY SYSTEM FOR VALSARTAN
    Publication number: 20100233253
    Abstract: An extended release gastro-retentive drug delivery system of Valsartan. The drug delivery system contains a release portion containing the Valsartan, a gastro-retentive portion for retaining the drug delivery system in the stomach and an optional secondary portion for delivering a secondary pulse of Valsartan. In another embodiment, there is provided a swellable unfolding membrane comprising Valsartan for sustained administration of Valsartan to the upper GI tract of a patient.
    Type: Application
    Filed: August 29, 2007
    Publication date: September 16, 2010
    Applicant: Novartis AG
    Inventors: Nikhil Javant Kavimandan, Jay Parthiban Lakshman, Arnol Singh Matharu, Joerg Ogorka, Alan Edward Royce, Noel Raj Teelucksingh